BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Treatment
9 results:

  • 1. A Clinical Prediction Model of Overall Survival for Patients with Cervical cancer Aged 25-69 Years.
    Fan W; Lu Q; Liu G
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984601
    [No Abstract]    [Full Text] [Related]  

  • 2. Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical cancer: Results from the EMBRACE-I Study.
    Kirchheiner K; Smet S; Jürgenliemk-Schulz IM; Haie-Meder C; Chargari C; Lindegaard JC; Fokdal LU; Spampinato S; Schmid MP; Sturdza A; Mahantshetty U; Segedin B; Bruheim K; Rai B; Cooper R; Van der Steen-Banasik E; Wiebe E; Sundset M; van Limbergen E; Villafranca E; Westerveld H; Tan LT; Pötter R; Tanderup K; Nout RA;
    Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):400-413. PubMed ID: 34478833
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Vesicoureteral Injury during Benign Hysterectomy: Minimally Invasive Laparoscopic Surgery versus Laparotomy.
    Chang EJ; Mandelbaum RS; Nusbaum DJ; Violette CJ; Matsushima K; Klar M; Matsuzaki S; Machida H; Kanao H; Roman LD; Matsuo K
    J Minim Invasive Gynecol; 2020; 27(6):1354-1362. PubMed ID: 31743796
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nuclear β-catenin and cdx2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome.
    Wang L; Rambau PF; Kelemen LE; Anglesio MS; Leung S; Talhouk A; Köbel M
    Histopathology; 2019 Feb; 74(3):452-462. PubMed ID: 30326146
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Yolk Sac Tumor in Extragonadal Pelvic Sites: Still a Diagnostic Challenge.
    Ravishankar S; Malpica A; Ramalingam P; Euscher ED
    Am J Surg Pathol; 2017 Jan; 41(1):1-11. PubMed ID: 27631522
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [A Case of Sigmoid Colon cancer with Metastasis to the Uterus].
    Tokoro Y; Tonooka T; Souda H; Takiguchi N; Chibana T; Kobayashi R; Arimitsu H; Yanagibashi H; Chou A; Ikeda A; Nabeya N; Kainuma O; Yamamoto H; Nagata M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1662-4. PubMed ID: 26805130
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel.
    Raspollini MR; Baroni G; Taddei A; Taddei GL
    Arch Pathol Lab Med; 2003 Dec; 127(12):1586-90. PubMed ID: 14632574
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial.
    Curtin JP; Hoskins WJ; Venkatraman ES; Almadrones L; Podratz KC; Long H; Teneriello M; Averette HA; Sevin BU
    Gynecol Oncol; 1996 Apr; 61(1):3-10. PubMed ID: 8626113
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Report on the clinical effects of inadvertent radiation underdosage in 1045 patients.
    Ash D; Bates T
    Clin Oncol (R Coll Radiol); 1994; 6(4):214-26. PubMed ID: 7527247
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.